Biomerica Reports First Quarter Fiscal 2025 Financial Results
Provided By GlobeNewswire
Last update: Oct 16, 2024
IRVINE, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic and therapeutic products today reported financial results for the first quarter of fiscal 2025 ended August 31, 2024.
Read more at globenewswire.comNASDAQ:BMRA (8/8/2025, 8:21:20 PM)
3.11
0 (0%)
Find more stocks in the Stock Screener
